NLRP3 and Alzheimer disease: Based on the above findings, it is conceivable that, in early AD mice, the enteric accumulation of AD-related proteins, with particular regard for Aβ, determines NLRP3 activation and mitochondrial dysfunctions, which, in turn, promote the occurrence of enteric neurogenic/inflammatory conditions that could contribute to alterations of bowel motility.